Evolving therapies for rifampicin-resistant tuberculosis: balancing efficacy and toxicity

Affiliations

¹ Department of Internal Medicine, University of the Witwatersrand, Johannesburg, South Africa; North West Province Department of Health, Mahikeng, South Africa; Perinatal HIV Research Unit, Soweto, South Africa. Electronic address: variava@worldonline.co.za.
² Perinatal HIV Research Unit, Soweto, South Africa; Soweto Matlosana South African Medical Research Council Collaborating Centre for HIV/AIDS and TB, University of the Witwatersrand, Johannesburg, South Africa; Johns Hopkins University Center for TB Research, Baltimore, MD, USA.
³ Perinatal HIV Research Unit, Soweto, South Africa.

Comment

Ebrahim Variava et al. Lancet Respir Med. 2020 Apr.

. 2020 Apr;8(4):326-328.

doi: 10.1016/S2213-2600(20)30038-2. Epub 2020 Mar 17.

¹ Department of Internal Medicine, University of the Witwatersrand, Johannesburg, South Africa; North West Province Department of Health, Mahikeng, South Africa; Perinatal HIV Research Unit, Soweto, South Africa. Electronic address: variava@worldonline.co.za.
² Perinatal HIV Research Unit, Soweto, South Africa; Soweto Matlosana South African Medical Research Council Collaborating Centre for HIV/AIDS and TB, University of the Witwatersrand, Johannesburg, South Africa; Johns Hopkins University Center for TB Research, Baltimore, MD, USA.
³ Perinatal HIV Research Unit, Soweto, South Africa.

No abstract available

Comment on

Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study.
Mishra H, Reeve BWP, Palmer Z, Caldwell J, Dolby T, Naidoo CC, Jackson JG, Schumacher SG, Denkinger CM, Diacon AH, van Helden PD, Marx FM, Warren RM, Theron G. Mishra H, et al. Lancet Respir Med. 2020 Apr;8(4):368-382. doi: 10.1016/S2213-2600(19)30370-4. Epub 2020 Feb 14. Lancet Respir Med. 2020. PMID: 32066534